Literature DB >> 9627799

The role of neutrophils as cytotoxic cells in lung metastasis: suppression of tumor cell metastasis by a biological response modifier (PSK).

Y Ishihara1, T Fujii, H Iijima, K Saito, K Matsunaga.   

Abstract

We aimed to determine the role of neutrophils and the usefulness of a protein-bound polysaccharide (PSK) in the suppression of tumor cell metastasis in the lung in vivo. Circulating neutrophils collected frm tumor-bearing animals (Line-10 hepatocarcinoma) induced a marked decrease in the size and number of metastatic foci in the lung. Although pulmonary macrophages (PAMs), lymphocyte and eosinophil in bronchoalveolar lavage (BAL) fluid increased following tumor cell inoculation, in addition to these findings we found that PSK caused an increase in BAL neutrophil levels causing increased of target cell toxicity and a marked decrease in the size and the number of lung metastatic foci. Superoxide anion generation of blood neutrophils collected from PSK-treated animals with metastasis showed forward acceleration. The presence of neutrophil chemotactic factors was confirmed in the BAL fluid of PSK-treated animals with metastasis, but not leukotriene B4. The results suggest that modulation of the tumor cell microenvironment by activation of neutrophils may prove to be an additional modality in treatment strategy by combining PSK as a biological response modifier with conventional therapies for lung metastasis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9627799

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  5 in total

Review 1.  Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function.

Authors:  A O Tzianabos
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Tumor-associated neutrophils display a distinct N1 profile following TGFβ modulation: A transcriptomics analysis of pro- vs. antitumor TANs.

Authors:  Merav E Shaul; Liran Levy; Jing Sun; Inbal Mishalian; Sunil Singhal; Veena Kapoor; Wenhwai Horng; Gil Fridlender; Steven M Albelda; Zvi G Fridlender
Journal:  Oncoimmunology       Date:  2016-09-13       Impact factor: 8.110

Review 3.  Immunostimulatory properties and antitumor activities of glucans (Review).

Authors:  Luca Vannucci; Jiri Krizan; Petr Sima; Dmitry Stakheev; Fabian Caja; Lenka Rajsiglova; Vratislav Horak; Mustafa Saieh
Journal:  Int J Oncol       Date:  2013-06-05       Impact factor: 5.650

Review 4.  Neutrophils in Cancer: Two Sides of the Same Coin.

Authors:  Eileen Uribe-Querol; Carlos Rosales
Journal:  J Immunol Res       Date:  2015-12-24       Impact factor: 4.818

5.  The Expression and Prognostic Impact of Immune Cytolytic Activity-Related Markers in Human Malignancies: A Comprehensive Meta-analysis.

Authors:  Constantinos Roufas; Dimitrios Chasiotis; Anestis Makris; Christodoulos Efstathiades; Christos Dimopoulos; Apostolos Zaravinos
Journal:  Front Oncol       Date:  2018-02-21       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.